What is the new medication for liver scarring? An overview of recent advances
•
3 min read
According to the [FDA](https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-treatment-serious-liver-disease-known-mash), approximately 6% of U.S. adults are affected by MASH, a serious liver disease that can lead to scarring (fibrosis). Recently, major advances have answered the question: **What is the new medication for liver scarring?** by bringing the first-ever medications specifically for this condition to market, offering new hope for treatment.
